SDMA
Symmetric dimethylarginine — a kidney function biomarker detectable in blood. SDMA rises when approximately 25% of kidney function is lost, compared to creatinine which rises only at 75% loss, enabling much earlier CKD detection.
SDMA (Symmetric Dimethylarginine) is a small molecule produced during normal protein metabolism and cleared entirely by the kidneys. Unlike creatinine — which requires ~75% loss of kidney function to consistently elevate — SDMA begins rising when approximately 25% of glomerular filtration rate is lost, enabling detection of chronic kidney disease (CKD) significantly earlier.
Why Earlier Detection Matters
Canine CKD is a progressive, irreversible disease — once nephrons (kidney filtration units) are lost, they do not regenerate. The practical implications of earlier detection:
- Dietary intervention: renal diets (phosphorus-restricted, moderate protein) slow CKD progression. Starting earlier, when more functional kidney mass remains, preserves function longer.
- Hydration management: increasing water intake (wet food, water fountains) reduces kidney workload. Earlier implementation means more benefit.
- Medication timing: ACE inhibitors for proteinuria, phosphorus binders, and other supportive medications can be initiated before clinical signs appear.
- Monitoring frequency: SDMA elevation triggers more frequent monitoring — catching rapid progression early.
SDMA vs. Creatinine
| Feature | SDMA | Creatinine |
|---|---|---|
| Kidney function lost at detection | ~25% | ~75% |
| Affected by muscle mass | No | Yes (low in muscle-wasted dogs) |
| Affected by diet | Minimal | Yes (high-protein meals raise BUN) |
| Added to standard panels | IDEXX panels include it | Standard for decades |
Creatinine remains clinically useful (especially for staging CKD), but SDMA provides the earlier warning signal.
Normal and Abnormal Values
- Normal SDMA: <14 µg/dL in most references (IDEXX reference <18 µg/dL for dogs)
- Borderline elevation: 14–18 µg/dL — warrants repeat testing and urine specific gravity
- Persistent elevation: confirms kidney function loss; stage accordingly per IRIS guidelines
SDMA should now be included in all senior dog wellness panels (>7 years) as standard, and in annual panels for dogs with known kidney risk factors (CKD history, recurrent UTI, protein-losing nephropathy breeds).